'US vaccine support to North Korea could help revive nuke talks'

Park Jie-won, head of South Korea's National Intelligence Service, on Monday said that Washington's possible proposal to provide Covid-19 vaccines to Pyongyang could serve help revive the talks

Coronavirus vaccine
IANS Seoul
2 min read Last Updated : Dec 13 2021 | 10:31 AM IST

Park Jie-won, head of South Korea's National Intelligence Service, on Monday said that Washington's possible proposal to provide Covid-19 vaccines to Pyongyang could serve help revive the long-stalled nuclear negotiations between the two nations.

"I believe that if the US rather more audaciously proposes providing its vaccines, momentum could be created to bring North Korea back to talks," Yonhap News Agency quoted the intel chief as saying at a forum in Seoul.

North Korea has imposed a strict border lockdown since last year and claims to be coronavirus-free.

The COVAX Facility, a global vaccine distribution platform, has assigned around 6.7 million doses of vaccines to the North, but Pyongyang remains unresponsive to the proposed vaccine assistance.

Park said the North could be discontented about not getting any return for maintaining its self-imposed moratorium on nuclear and long-range missile tests for the past four years.

"The US expressing interest in some way on lifting sanctions related to the livelihoods of (North Korean) people -- such as refined oil imports, coal and mineral exports and daily necessities imports -- could be a clue to resume talks for the peace on the Korean Peninsula," he said.

Park again urged Pyongyang to respond to calls for dialogue on issues of mutual interest, including Seoul's push to declare a formal end to the 1950-53 Korean War, and said the "hostile policy" and "double standards" could be among the agenda items.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :United StatesNorth KoreaCoronavirus Vaccine

First Published: Dec 13 2021 | 10:31 AM IST

Next Story